Mini Review

Published on 21 May 2024

Understanding iron homeostasis in MDS: the role of erythroferrone

in Hematologic Malignancies

Mohammed L. Abba
Vladimir Riabov
Daniel Nowak
Wolf-Karsten Hofmann
Tobias Boch

Frontiers in Oncology

doi 10.3389/fonc.2024.1404817

894 views

Original Research

Published on 21 May 2024

A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience

in Hematologic Malignancies

Magdalena Karasek
Anna Armatys
Marek Skarupski
Łukasz Bołkun
Katarzyna Budziszewska
Joanna Drozd-Sokołowska
Ewa Zarzycka
Patrycja Mensah-Glanowska
Małgorzata Gajewska
Janusz Hałka

Frontiers in Oncology

doi 10.3389/fonc.2024.1395992

1,076 views

Case Report

Published on 21 May 2024

Spinal myeloid sarcoma presenting as initial symptom in acute promyelocytic leukemia with a rare cryptic PLZF::RARα fusion gene: a case report and literature review

in Hematologic Malignancies

Xuejiao Zhang
Tao Wang
Pu Chen
Yan Chen
Zhimei Wang
Tianhong Xu
Pengfei Yu
Peng Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1375737

927 views

Case Report

Published on 17 May 2024

Case report: Lymph node metastasis of pelvic alveolar rhabdomyosarcoma diagnosed by fine needle aspiration cytology

in Hematologic Malignancies

Xinyu Hu
Chenxin Huang
Qiyuan Li
Baolin Wu
Chuyun Yue
Xueying Su

Frontiers in Oncology

doi 10.3389/fonc.2024.1340865

765 views

Brief Research Report

Published on 17 May 2024

Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

in Hematologic Malignancies

Darrell White
Gary J. Schiller
Sumit Madan
Suzanne Lentzsch
Evgeni Chubar
Noa Lavi
Dane R. Van Domelen
Ohad S. Bentur
Muhamed Baljevic

Frontiers in Oncology

doi 10.3389/fonc.2024.1352281

2,286 views
1 citation

Review

Published on 16 May 2024

An overview of prognostic markers in patients with CLL

in Hematologic Malignancies

Julie Braish
Claudio Cerchione
Alessandra Ferrajoli

Frontiers in Oncology

doi 10.3389/fonc.2024.1371057

3,221 views
3 citations

Original Research

Published on 13 May 2024

Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients

in Hematologic Malignancies

Edoardo Benedetti
Ginevra Traverso
Giulia Pucci
Riccardo Morganti
Emilia Bramanti
Federica Cavallo
Enrico Capochiani
Maurizio De Maria
Vittorio Ricchiuto
Massimo Salvatore Stella

Frontiers in Oncology

doi 10.3389/fonc.2024.1369601

807 views

Original Research

Published on 10 May 2024

Activated interferon response from DNA damage in multiple myeloma cells contributes to the chemotherapeutic effects of anthracyclines

in Hematologic Malignancies

Jin Li
Zhuxia Jia
Rongxuan Wang
Bitao Xiao
Yanan Cai
Tianshu Zhu
Weiya Wang
Xinyue Zhang
Shu Fan
Xiaolong Fan

Frontiers in Oncology

doi 10.3389/fonc.2024.1357996

1,033 views
1 citation

Review

Published on 10 May 2024

Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma

in Hematologic Malignancies

Kevin Miller
Hamza Hashmi
Sridevi Rajeeve

Frontiers in Oncology

doi 10.3389/fonc.2024.1398902

3,551 views
1 citation

Brief Research Report

Published on 08 May 2024

Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study

in Hematologic Malignancies

Bruna Murbach
Gislaine Duarte
Leonardo Carvalho Palma
Eliana Miranda
Guilherme Duffles
Graziele Pavan Furlin
Isabella Toni
Carmino De Souza
Larissa Binelli
Vitor Leonardo Bassan

Frontiers in Oncology

doi 10.3389/fonc.2024.1393191

1,614 views

Case Report

Published on 03 May 2024

Case report: ‘Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient’

in Hematologic Malignancies

Annaïse J. Jauch
Ilaria Alborelli
Andreas Reusser
Albert Baschong
Cyrill Rütsche
Olivier Bignucolo
Jakob Passweg
Stefan Dirnhofer
Fatime Krasniqi

Frontiers in Oncology

doi 10.3389/fonc.2024.1296238

1,316 views

Editorial

Published on 02 May 2024

Editorial: Reviews in hematologic malignancies: 2023

in Hematologic Malignancies

Billy Michael Chelliah Jebaraj
Michael Liew
Felix Seyfried

Frontiers in Oncology

doi 10.3389/fonc.2024.1412843

794 views

Case Report

Published on 02 May 2024

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report

in Hematologic Malignancies

Elisa Diral
Gloria Catalano
Maria Vittoria Cicinelli
Andrea Distefano
Sara Mastaglio
Luca Vago
Maria Teresa Lupo Stanghellini
Massimo Bernardi
Maurilio Ponzoni
Fabio Ciceri

Frontiers in Oncology

doi 10.3389/fonc.2024.1399894

675 views

Original Research

Published on 02 May 2024

Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia

in Hematologic Malignancies

Claudia Núñez-Torrón Stock
Carlos Jiménez Chillón
Fernando Martín Moro
Juan Marquet Palomanes
Miguel Piris Villaespesa
Ernesto Roldán Santiago
Eulalia Rodríguez Martín
Anabelle Chinea Rodríguez
Valentín García Gutiérrez
Gemma Moreno Jiménez

Frontiers in Oncology

doi 10.3389/fonc.2024.1394648

1,003 views

Case Report

Published on 01 May 2024

Osteolytic lesions as a presenting sign of acute myeloid leukemia: a case report

in Hematologic Malignancies

Jingqian Zhang
Shidai Mu
Li Cai
Lisha Ai
Yaohui Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1364266

958 views

Case Report

Published on 26 Apr 2024

A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine

in Hematologic Malignancies

Mengci Hu
Wenzhe Li
Pan Li
Jie Tan
Ya Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1329279

1,215 views

Navigation group

Articles

Understanding iron homeostasis in MDS: the role of erythroferrone

A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience

Spinal myeloid sarcoma presenting as initial symptom in acute promyelocytic leukemia with a rare cryptic PLZF::RARα fusion gene: a case report and literature review

Case report: Lymph node metastasis of pelvic alveolar rhabdomyosarcoma diagnosed by fine needle aspiration cytology

Efficacy and safety of once weekly selinexor 40 mg versus 60 mg with pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma

An overview of prognostic markers in patients with CLL

Prospective study on the impact of BEAM versus FEAM conditioning on occurrence of neutropenic enterocolitis and on transplant outcome in lymphoma patients

Activated interferon response from DNA damage in multiple myeloma cells contributes to the chemotherapeutic effects of anthracyclines

Beyond BCMA: the next wave of CAR T cell therapy in multiple myeloma

Kinetics of BCR::ABL1 transcript levels and molecular relapse after tyrosine kinase inhibitors discontinuation in chronic myeloid leukemia patients: preliminary results from the DES-CML study

Case report: ‘Atypical Richter transformation from CLL-type monoclonal B-cell lymphocytosis into Burkitt lymphoma in a treatment naïve patient’

Editorial: Reviews in hematologic malignancies: 2023

Spontaneous remission of choroidal involvement by chronic myelomonocytic leukemia: a case report

Survival after allogeneic transplantation according to pretransplant minimal residual disease and conditioning intensity in patients with acute myeloid leukemia

Osteolytic lesions as a presenting sign of acute myeloid leukemia: a case report

A case report of secondary B-cell acute lymphoblastic leukemia treated with a combination of FLT3 inhibitor and decitabine